Eastgate BiotechETBI
13F holders, Q2 2024 (June 30)1holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Eastgate Biotech Corp. (ETBI) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was Associated Banc-Corp ($1K).
- Company
- Eastgate Biotech Corp.
- CUSIP
- 277253100
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Associated Banc-Corp | 0.00% | No change | 288,600 | $1K |
"% of holder's portfolio" is ETBI's weight in each manager's 13F, not the share of Eastgate Biotech Corp. the manager owns.